Evelo Biosciences

About Evelo Biosciences

The gut is a central organ of the immune system which controls immunity and inflammation through its interactions with microbes in the small intestine

We are developing a new class of oral biologic therapies that engage immune cells in the small intestine to transmit effects throughout the body

Modulation of this “gut-body network" has therapeutic potential in many major diseases

For general inquiries contact: info@evelobio.com

For media inquiries contact: media@evelobio.com

For investor inquiries contact: ir@evelobio.com

NASDAQ EVLO